BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36739599)

  • 1. Tantalum-Zirconium Co-Doped Metal-Organic Frameworks Sequentially Sensitize Radio-Radiodynamic-Immunotherapy for Metastatic Osteosarcoma.
    Li T; Gao M; Wu Z; Yang J; Mo B; Yu S; Gong X; Liu J; Wang W; Luo S; Li R
    Adv Sci (Weinh); 2023 Apr; 10(10):e2206779. PubMed ID: 36739599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen-Evolving Radiotherapy-Radiodynamic Therapy Synergized with NO Gas Therapy by Cerium-Based Rare-Earth Metal-Porphyrin Framework.
    Lin J; He Y; Li Y; Chen J; Liu X
    Small; 2024 May; ():e2310957. PubMed ID: 38698608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. π-Extended Benzoporphyrin-Based Metal-Organic Framework for Inhibition of Tumor Metastasis.
    Zeng JY; Zou MZ; Zhang M; Wang XS; Zeng X; Cong H; Zhang XZ
    ACS Nano; 2018 May; 12(5):4630-4640. PubMed ID: 29584395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen-Enriched Metal-Phenolic X-Ray Nanoprocessor for Cancer Radio-Radiodynamic Therapy in Combination with Checkpoint Blockade Immunotherapy.
    Sang W; Xie L; Wang G; Li J; Zhang Z; Li B; Guo S; Deng CX; Dai Y
    Adv Sci (Weinh); 2021 Feb; 8(4):2003338. PubMed ID: 33643804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of anti-PD-1/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework.
    Ge YX; Zhang TW; Zhou L; Ding W; Liang HF; Hu ZC; Chen Q; Dong J; Xue FF; Yin XF; Jiang LB
    Biomaterials; 2022 Mar; 282():121407. PubMed ID: 35217343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrathin metal-organic layer-mediated radiotherapy-radiodynamic therapy enhances immunotherapy of metastatic cancers.
    Ni K; Lan G; Chan C; Duan X; Guo N; Veroneau SS; Weichselbaum RR; Lin W
    Matter; 2019 Nov; 1(5):1331-1353. PubMed ID: 32832885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic checkpoint-blockade and radiotherapy-radiodynamic therapy via an immunomodulatory nanoscale metal-organic framework.
    Ni K; Xu Z; Culbert A; Luo T; Guo N; Yang K; Pearson E; Preusser B; Wu T; La Riviere P; Weichselbaum RR; Spiotto MT; Lin W
    Nat Biomed Eng; 2022 Feb; 6(2):144-156. PubMed ID: 35190678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose X-ray radiodynamic therapy solely based on gold nanoclusters for efficient treatment of deep hypoxic solid tumors combined with enhanced antitumor immune response.
    Zhu S; Yan F; Yang L; Li B; Xue R; Yu W; Wang Y; Huang L; Wang L; Han R; Jiang Y
    Theranostics; 2023; 13(3):1042-1058. PubMed ID: 36793856
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of Topology on Photodynamic Sterilization of Porphyrinic Metal-Organic Frameworks.
    Liu YY; Chen LJ; Zhao X; Yan XP
    Chemistry; 2021 Jul; 27(39):10151-10159. PubMed ID: 33978976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoscale Metal-Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy.
    Ni K; Luo T; Culbert A; Kaufmann M; Jiang X; Lin W
    J Am Chem Soc; 2020 Jul; 142(29):12579-12584. PubMed ID: 32658476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoscale Metal-Organic Layers for Radiotherapy-Radiodynamic Therapy.
    Lan G; Ni K; Veroneau SS; Song Y; Lin W
    J Am Chem Soc; 2018 Dec; 140(49):16971-16975. PubMed ID: 30485084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of Neutrophils as Non-canonical Antigen Presenting Cells by Radiotherapy-Radiodynamic Therapy to Facilitate Immune-Mediated Tumor Regression.
    Guo N; Ni K; Luo T; Lan G; Arina A; Xu Z; Mao J; Weichselbaum RR; Spiotto M; Lin W
    ACS Nano; 2021 Nov; 15(11):17515-17527. PubMed ID: 34709030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming Cold Tumors into Hot Ones with a Metal-Organic Framework-Based Biomimetic Nanosystem for Enhanced Immunotherapy.
    Xu M; Chang Y; Zhu G; Zhu X; Song X; Li J
    ACS Appl Mater Interfaces; 2023 Apr; 15(14):17470-17484. PubMed ID: 36995264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy.
    Du C; Zhou M; Jia F; Ruan L; Lu H; Zhang J; Zhu B; Liu X; Chen J; Chai Z; Hu Y
    Biomaterials; 2021 Feb; 269():120642. PubMed ID: 33440291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy.
    Ni K; Lan G; Veroneau SS; Duan X; Song Y; Lin W
    Nat Commun; 2018 Oct; 9(1):4321. PubMed ID: 30333489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal-Organic Framework-Based Nano-Activators Facilitating Microwave Combined Therapy via a Divide-and-Conquer Tactic for Triple-Negative Breast Cancer.
    Wu Q; Tan L; Ren X; Fu C; Chen Z; Ren J; Ma T; Meng X
    ACS Nano; 2023 Dec; 17(24):25575-25590. PubMed ID: 38095158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monte Carlo Simulation-Guided Design of a Thorium-Based Metal-Organic Framework for Efficient Radiotherapy-Radiodynamic Therapy.
    Xu Z; Luo T; Mao J; McCleary C; Yuan E; Lin W
    Angew Chem Int Ed Engl; 2022 Nov; 61(46):e202208685. PubMed ID: 36149753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal-Organic Framework-Based Nanoagents for Effective Tumor Therapy by Dual Dynamics-Amplified Oxidative Stress.
    Chen J; Wang Y; Niu H; Wang Y; Wu A; Shu C; Zhu Y; Bian Y; Lin K
    ACS Appl Mater Interfaces; 2021 Sep; 13(38):45201-45213. PubMed ID: 34525803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy.
    Luo J; Wang X; Shi Z; Zeng Y; He L; Cao J; Sun Y; Zhang T; Huang P
    J Nanobiotechnology; 2022 May; 20(1):228. PubMed ID: 35568916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.